StockViz
RANKINGS
Exicure, Inc.
NasdaqCM:XCUR
Sector
Industries
Location
Market Cap
USD 37.65 M
Share Price
USD 5.96
Avg Daily Volume
20,585
Change (1 day)
-2.30%
Change (1 year)
284.52%
Change (YTD)
-56.40%
Exicure, Inc. Income Statement 2016 - 2024
This table shows the Income Statement for Exicure, Inc. going from 2016 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement
| Annual data in millions of USD, except per share data | Trend |
|---|
Competitors
AbbVie Inc.
USD 190.75
ABBV
+0.76
0.40%
Novo Nordisk A/S
USD 69.62
NOVO-B.CO
+0.45
0.65%
Roche Holding AG
USD 347.68
RO.SW
-0.20
-0.06%
Novartis AG
USD 123.90
NOVN.SW
+0.42
0.34%
Abbott Laboratories
USD 134.11
ABT
-2.15
-1.58%
AstraZeneca PLC
USD 141.63
AZN.L
-1.32
-0.93%
Merck & Co., Inc.
USD 82.39
MRK
+0.58
0.71%
Amgen Inc.
USD 296.85
AMGN
+6.33
2.18%
Pfizer Inc.
USD 25.32
PFE
+0.28
1.12%
Gilead Sciences, Inc.
USD 111.51
GILD
-0.22
-0.20%
Sanofi
USD 98.65
SAN.PA
+0.57
0.58%
Vertex Pharmaceuticals Incorporated
USD 457.03
VRTX
+4.87
1.08%
Bristol-Myers Squibb Company
USD 47.63
BMY
+0.12
0.25%
Chugai Pharmaceutical Co., Ltd.
USD 48.90
4519.T
-0.57
-1.16%
GSK plc
USD 19.21
GSK.L
-0.20
-1.02%
CSL Limited
USD 159.11
CSL.AX
+1.27
0.80%
Zoetis Inc.
USD 159.08
ZTS
-0.11
-0.07%
Regeneron Pharmaceuticals, Inc.
USD 547.74
REGN
+12.83
2.40%
MERCK Kommanditgesellschaft auf Aktien
USD 132.97
MRK.DE
+0.27
0.20%
Lonza Group AG
USD 703.42
LONN.SW
-7.98
-1.12%